Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) - Global Forecast to 2026

September 2021 | 334 pages | ID: P1B430983C2EN
MarketsandMarkets

Abstracts

The protein characterization and identification market is projected to reach USD 23.9 billion by 2026 from USD 12.6 billion in 2021, at a CAGR of 13.7% during the forecast period, owing togrowing acceptance of personalized medicine, increased expenditure in R&D for drug discovery and development, technological advancements, and growth in proteomics research.

“By product & service, theconsumables segment accountedfor the largest share of the protein characterization and identificationmarket”

The protein characterization and identificationmarket by product & service is categorized into consumables, instruments, and services. The consumables segment is further divided into immunoassay consumables, mass spectrometry consumables, chromatography consumables, electrophoresis consumables, and other consumables. The instruments segment is further dividedmass spectrometry instrument, chromatography instrument, electrophoresis instrument, label-free detection instrument, spectroscopy instrument, and other instruments. The services segment is further divided based on the applications such as drug discovery & development, clinical diagnosis, and other applications. The consumables segment dominated the market in 2020. The large share of this segment can be attributed torisingavailability of a wide range of reagents and the need for reliable, specific, and rapid detection of diseases at the early stages.

“Asia Pacific: The fastest-growing region in the protein characterization and identificationmarket.”

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to rising prevalence of chronic diseases, geographical expansion by prominent market players, and increasing demand for high-quality analytical tools for protein analysis.

“North America: the largest share of the protein characterization and identificationmarket”

North America accounted for the largest share of the protein characterization and identificationmarket. Availability of funds for innovative technologies from government organizations, growing number of agreements and collaborations among large companies, and increasing R&D investments in proteomics researchare the major factors driving the market growth in the region.

Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 70%, Demand Side- 30%
• By Designation— Executives- 25%, CXOs&Directors--30%, Managers - 45%
• By Region— North America - 40%, Europe - 25%, APAC – 20%, LATAM- 10%, MEA- 5%

The protein characterization and identificationmarket is dominated by a few globally established players such as including Thermo Fisher Scientific (US), Merck KGaA (Germany), Danaher Corporation (US), Agilent Technologies (US), Waters Corporation (US), Creative Proteomics (US), Rigaku Corporation (Japan), Analytik Jena (Germany), VProteomics (India), Promega Corporation (US), Sartorius AG (Germany), HORIBA Ltd. (Japan), QIAGEN N.V. (Netherlands), Cleaver Scientific (UK), JEOL Ltd. (Japan), MS Bioworks (US), MassTech Inc. (US), Advion, Inc. (US), and SERVA Electrophoresis GmbH (Germany).

Research Coverage:

The report segments the protein characterization and identificationmarket based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), product & service(consumables (immunoassay consumables, mass spectrometry consumables, chromatography consumables, electrophoresis consumables, and other consumables), instruments (mass spectrometry instrument, chromatography instrument, electrophoresis instrument, label-free detection instrument, spectroscopy instrument, and other instruments), and services (drug discovery & development, clinical diagnosis, and other applications), application (drug discovery & development, clinical diagnosis, and other applications), and end user (pharmaceutical & biotechnology companies, academic research institutes, contract research organization (CROs) and other end users).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the protein characterization and identificationmarket.

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the protein characterization and identificationmarket and provides them information on key market drivers, challenges, and opportunities.

Contents

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
  1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATION
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
  2.1.2 PRIMARY DATA
FIGURE 3 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF PROTEIN CHARACTERIZATION AND IDENTIFICATION IN THE MARKET
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2020
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: CAGR PROJECTIONS, 2021–2026
FIGURE 8 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
  2.6.1 COVID-19 SPECIFIC ASSUMPTIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

FIGURE 12 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 14 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER 2021 VS. 2026 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET

4 PREMIUM INSIGHTS

4.1 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW
FIGURE 16 RISING &&D EXPENDITURE TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET SHARE, BY PRODUCT & COUNTRY (2020)
FIGURE 17 CONSUMABLES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
IN 2020
4.3 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 THE CONSUMABLES SEGMENT WILL DOMINATE THE MARKET IN 2026
4.4 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET SHARE, BY END USER, 2020
FIGURE 19 THE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.5 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH FROM 2021 TO 2026

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: IMPACT ANALYSIS
  5.2.1 DRIVERS
  5.2.1.1 Growing acceptance of personalized medicines
FIGURE 22 NUMBER OF PERSONALIZED MEDICINES IN THE MARKET, 2008–2020
  5.2.1.2 Increased R&D expenditure for drug discovery and development
FIGURE 23 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2016
  5.2.1.3 Technological advancements
  5.2.1.4 Growth in proteomics research
  5.2.2 RESTRAINTS
  5.2.2.1 High cost of instruments
  5.2.3 OPPORTUNITIES
  5.2.3.1 Emerging markets
  5.2.3.2 Growing prominence of nanoproteomics
  5.2.4 CHALLENGES
  5.2.4.1 Dearth of skilled professionals
5.3 IMPACT OF COVID-19 ON THE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
FIGURE 24 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021

6 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE

6.1 INTRODUCTION
TABLE 2 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 3 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
6.2 CONSUMABLES
TABLE 4 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 5 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 6 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 7 PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 8 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 9 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 10 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 11 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 12 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 13 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.2.1 IMMUNOASSAY CONSUMABLES
  6.2.1.1 Immunoassay consumables to dominate the consumables market during the forecast period
TABLE 14 IMMUNOASSAY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 15 IMMUNOASSAY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 17 NORTH AMERICA: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 18 EUROPE: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 19 EUROPE: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 20 ASIA PACIFIC: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 21 ASIA PACIFIC: IMMUNOASSAY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.2.2 MASS SPECTROMETRY CONSUMABLES
  6.2.2.1 Increased use of mass spectrometry-based approaches supports segment growth
TABLE 22 MASS SPECTROMETRY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 23 MASS SPECTROMETRY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 24 NORTH AMERICA: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 25 NORTH AMERICA: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 26 EUROPE: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 27 EUROPE: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 29 ASIA PACIFIC: MASS SPECTROMETRY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.2.3 CHROMATOGRAPHY CONSUMABLES
  6.2.3.1 Increasing demand for chromatography reagents and columns for protein analysis to drive segment growth
TABLE 30 CHROMATOGRAPHY CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 31 CHROMATOGRAPHY CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 32 NORTH AMERICA: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 33 NORTH AMERICA: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 34 EUROPE: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 35 EUROPE: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 36 ASIA PACIFIC: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 37 ASIA PACIFIC: CHROMATOGRAPHY CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.2.4 ELECTROPHORESIS CONSUMABLES
  6.2.4.1 Increasing demand for 2D electrophoresis is driving the adoption of consumables
TABLE 38 ELECTROPHORESIS CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 39 ELECTROPHORESIS CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 41 NORTH AMERICA: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 42 EUROPE: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 43 EUROPE: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 45 ASIA PACIFIC: ELECTROPHORESIS CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.2.5 OTHER CONSUMABLES
TABLE 46 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 47 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 49 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 50 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 51 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 52 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 53 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.3 INSTRUMENTS
TABLE 54 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 55 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 56 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 57 PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 59 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 60 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 61 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 62 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 63 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.1 MASS SPECTROMETRY INSTRUMENTS
  6.3.1.1 Mass spectrometry instruments hold the largest share of
the instruments market
TABLE 64 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 65 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 67 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 68 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 69 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 70 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 71 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.2 CHROMATOGRAPHY INSTRUMENTS
  6.3.2.1 Advancements in HPLC for protein characterization drives the market growth
TABLE 72 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 73 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 75 NORTH AMERICA: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 76 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 77 EUROPE: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 78 ASIA PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 79 ASIA PACIFIC: CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.3 ELECTROPHORESIS INSTRUMENTS
  6.3.3.1 Simplicity and technological advancements in electrophoresis drive market growth
TABLE 80 ELECTROPHORESIS INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 81 ELECTROPHORESIS INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 82 NORTH AMERICA: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 83 NORTH AMERICA: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 84 EUROPE: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 85 EUROPE: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 86 ASIA PACIFIC: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 87 ASIA PACIFIC: ELECTROPHORESIS INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.4 LABEL-FREE DETECTION INSTRUMENTS
  6.3.4.1 Extensive use of label-free detection for biologic and new product development to drive the market
TABLE 88 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 89 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 91 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 92 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 93 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 95 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.5 SPECTROSCOPY INSTRUMENTS
  6.3.5.1 The ability of MS to identify small amounts of protein from increasingly complex mixtures will drive segment growth
TABLE 96 SPECTROSCOPY INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 97 SPECTROSCOPY INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 98 NORTH AMERICA: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 99 NORTH AMERICA SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 100 EUROPE: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 101 EUROPE: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 102 ASIA PACIFIC: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 103 ASIA PACIFIC: SPECTROSCOPY INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
  6.3.6 OTHER INSTRUMENTS
TABLE 104 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 105 OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 106 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 107 NORTH AMERICA: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 108 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 109 EUROPE: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 111 ASIA PACIFIC: OTHER PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
6.4 SERVICES
  6.4.1 THE INCREASING USE OF PROTEIN IDENTIFICATION AND CHARACTERIZATION SERVICES BY PHARMACEUTICAL AND BIOTECH COMPANIES BOOSTS SEGMENT GROWTH
TABLE 112 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: SERVICES & SERVICE PROVIDERS
TABLE 113 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 114 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY REGION, 2021–2026 (USD MILLION)
TABLE 115 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 116 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 117 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 118 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 120 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 121 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 122 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 123 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2017–2020 (USD MILLION)
TABLE 124 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
TABLE 125 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 126 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 127 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 128 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 130 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 131 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2017–2020 (USD MILLION)
TABLE 132 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2021–2026 (USD MILLION)
TABLE 133 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 134 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 135 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 136 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 137 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 138 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 139 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2020 (USD MILLION)
TABLE 140 PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 141 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 142 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 143 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 144 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 145 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 146 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)

7 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION

7.1 INTRODUCTION
TABLE 147 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 148 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
7.2 DRUG DISCOVERY & DEVELOPMENT
  7.2.1 INCREASED FOCUS ON DRUG DISCOVERY AND DEVELOPMENT WILL BOOST THE MARKET GROWTH
TABLE 149 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2017–2020 (USD MILLION)
TABLE 150 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021–2026 (USD MILLION)
TABLE 151 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 152 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 153 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 154 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 156 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021–2026 (USD MILLION)
7.3 CLINICAL DIAGNOSIS
  7.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
TABLE 157 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2017–2020 (USD MILLION)
TABLE 158 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY REGION, 2021–2026 (USD MILLION)
TABLE 159 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 160 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 161 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 162 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 164 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CLINICAL DIAGNOSIS, BY COUNTRY, 2021–2026 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 165 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2020 (USD MILLION)
TABLE 166 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2026 (USD MILLION)
TABLE 167 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 168 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 169 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 170 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 171 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 172 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2026 (USD MILLION)

8 PROTEIN CHARACTERIZATION & IDENTIFICATION MARKET, BY END USER

8.1 INTRODUCTION
TABLE 173 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 174 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  8.2.1 INCREASED EMPHASIS ON DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
FIGURE 25 ANNUAL DRUG APPROVALS BY THE FDA CDER (2011–2020)
TABLE 175 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2020 (USD MILLION)
TABLE 176 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2026 (USD MILLION)
TABLE 177 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 178 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 179 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 180 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 181 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 182 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2026 (USD MILLION)
8.3 ACADEMIC RESEARCH INSTITUTES
  8.3.1 INCREASED FUNDING FOR PROTEOMIC RESEARCH WILL DRIVE THE GROWTH OF THE MARKET
TABLE 183 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2017–2020 (USD MILLION)
TABLE 184 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2021–2026 (USD MILLION)
TABLE 185 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 186 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 187 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 188 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 189 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 190 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2021–2026 (USD MILLION)
8.4 CONTRACT RESEARCH ORGANIZATIONS
  8.4.1 INCREASED FOCUS ON THE DEVELOPMENT OF NOVEL DRUGS DRIVING
THE MARKET GROWTH
TABLE 191 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY REGION, 2017–2020 (USD MILLION)
TABLE 192 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY REGION, 2021–2026 (USD MILLION)
TABLE 193 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 194 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 195 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 196 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 197 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 198 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR CROS, BY COUNTRY, 2021–2026 (USD MILLION)
8.5 OTHER END USERS
TABLE 199 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER
END USERS, BY REGION, 2017–2020 (USD MILLION)
TABLE 200 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER
END USERS, BY REGION, 2021–2026 (USD MILLION)
TABLE 201 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 202 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 203 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 204 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 205 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 206 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)

9 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY REGION

9.1 INTRODUCTION
TABLE 207 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY REGION, 2017–2020 (USD MILLION)
TABLE 208 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY REGION, 2021–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET SNAPSHOT
TABLE 209 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 210 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 211 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 212 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 213 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 214 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 215 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 216 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 217 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 218 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 219 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 220 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 221 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 222 NORTH AMERICA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.2.1 US
  9.2.1.1 The US dominates the protein characterization and identification market during the forecast period
TABLE 223 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 224 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 225 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 226 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 227 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 228 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 229 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 230 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 231 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 232 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 233 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 234 US: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.2.2 CANADA
  9.2.2.1 Growing focus on patented therapies and diagnostics and increased R&D expenditure promote market growth
TABLE 235 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 236 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 237 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 238 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 239 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 240 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 241 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 242 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 243 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 244 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 245 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 246 CANADA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3 EUROPE
TABLE 247 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 248 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 249 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 250 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 251 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 252 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 253 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 254 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 255 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 256 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 257 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 258 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 259 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 260 EUROPE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.1 GERMANY
  9.3.1.1 Germany dominates the protein characterization and identification market in Europe
TABLE 261 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 262 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 263 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 264 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 265 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 266 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 267 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 268 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 269 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 270 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 271 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 272 GERMANY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.2 UK
  9.3.2.1 Increasing investment in the biotech industry and surge in
the prevalence of chronic diseases to drive market growth
TABLE 273 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 274 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 275 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 276 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 277 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 278 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 279 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 280 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 281 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 282 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 283 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 284 UK: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.3 FRANCE
  9.3.3.1 Increasing personalized medicine to increase the market growth
TABLE 285 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 286 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 287 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 288 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 289 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 290 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 291 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 292 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 293 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 294 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 295 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 296 FRANCE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.4 ITALY
  9.3.4.1 Growth of the life science industry to expand market growth
TABLE 297 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 298 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 299 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 300 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 301 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 302 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 303 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 304 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 305 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 306 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 307 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 308 ITALY: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.5 SPAIN
  9.3.5.1 Innovation and increased R&D funding to maximize market growth
TABLE 309 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 310 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 311 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 312 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 313 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 314 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 315 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 316 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 317 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 318 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 319 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 320 SPAIN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.3.6 REST OF EUROPE
TABLE 321 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 322 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 323 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 324 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 325 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 326 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 327 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 328 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 329 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 330 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 331 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 332 ROE: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET SNAPSHOT
TABLE 333 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
TABLE 334 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 335 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 336 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 337 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 338 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 339 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 340 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 341 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 342 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 343 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 344 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 345 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 346 ASIA PACIFIC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.4.1 CHINA
  9.4.1.1 Government initiatives and foreign investments for R&D to prompt market growth
TABLE 347 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 348 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 349 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 350 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 351 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 352 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 353 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 354 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 355 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 356 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 357 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 358 CHINA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.4.2 JAPAN
  9.4.2.1 The growth of the biopharmaceutical sector will promote market growth in Japan
TABLE 359 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 360 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 361 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 362 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 363 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 364 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 365 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 366 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 367 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 368 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 369 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 370 JAPAN: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.4.3 INDIA
  9.4.3.1 Government initiatives and increased proteomics research to boost the market growth
TABLE 371 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 372 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 373 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 374 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 375 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 376 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 377 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 378 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 379 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 380 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 381 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 382 INDIA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
  9.4.4 ROAPAC
TABLE 383 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 384 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 385 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 386 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 387 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 388 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 389 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 390 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 391 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 392 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 393 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 394 ROAPAC: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.5 LATIN AMERICA
  9.5.1 RISING PUBLIC-PRIVATE PARTNERSHIPS AND GROWING GOVERNMENT INVESTMENTS TO SUPPORT THE MARKET GROWTH
TABLE 395 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 396 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 397 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 398 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 399 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 400 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 401 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 402 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 403 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 404 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 405 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 406 LATAM: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
  9.6.1 GROWTH IN THE PHARMACEUTICAL MARKET AND EXPANSION BY TOP PHARMACEUTICAL COMPANIES TO PROMOTE GROWTH OF MARKET
TABLE 407 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2017–2020 (USD MILLION)
TABLE 408 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)
TABLE 409 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 410 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 411 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2017–2020 (USD MILLION)
TABLE 412 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 413 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 414 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION SERVICES MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 415 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2017–2020 (USD MILLION)
TABLE 416 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION, 2021–2026 (USD MILLION)
TABLE 417 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2017–2020 (USD MILLION)
TABLE 418 MEA: PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END USER, 2021–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 28 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: STRATEGIES ADOPTED
10.3 REVENUE ANALYSIS
FIGURE 29 REVENUE ANALYSIS FOR KEY COMPANIES OVER THE PAST THREE YEARS
10.4 MARKET SHARE ANALYSIS
FIGURE 30 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
10.5 COMPANY EVALUATION MATRIX
  10.5.1 STARS
  10.5.2 EMERGING LEADERS
  10.5.3 PERVASIVE PLAYERS
  10.5.4 PARTICIPANTS
FIGURE 31 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: COMPANY EVALUATION MATRIX, 2020
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES
  10.6.1 PROGRESSIVE COMPANIES
  10.6.2 STARTING BLOCKS
  10.6.3 RESPONSIVE COMPANIES
  10.6.4 DYNAMIC COMPANIES
FIGURE 32 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2020
10.7 COMPETITIVE BENCHMARKING
  10.7.1 COMPANY PRODUCT & SERVICE FOOTPRINT (20 COMPANIES)
FIGURE 33 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
  10.7.2 COMPANY PRODUCT & SERVICE OFFERING FOOTPRINT (20 COMPANIES)
TABLE 419 PRODUCT & SERVICE OFFERING FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
  10.7.3 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
TABLE 420 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN THE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET
10.8 COMPETITIVE SCENARIO AND TRENDS
  10.8.1 PRODUCT & SERVICE LAUNCHES
TABLE 421 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET:
PRODUCT & SERVICE LAUNCHES, JANUARY 2017–AUGUST 2021
  10.8.2 DEALS
TABLE 422 PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET:
DEALS, JANUARY 2017–AUGUST 2021

11 COMPANY PROFILES

11.1 KEY COMPANIES
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
  11.1.1 DANAHER CORPORATION
TABLE 423 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 34 DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 424 DANAHER CORPORATION: PRODUCT OFFERINGS
  11.1.2 MERCK KGAA
TABLE 425 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT
TABLE 426 MERCK KGAA: PRODUCT & SERVICE OFFERINGS
  11.1.3 THERMO FISHER SCIENTIFIC
TABLE 427 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 428 THERMO FISHER SCIENTIFIC: PRODUCT OFFERINGS
  11.1.4 AGILENT TECHNOLOGIES
TABLE 429 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
FIGURE 37 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 430 AGILENT TECHNOLOGIES: PRODUCT OFFERINGS
  11.1.5 WATERS CORPORATION
TABLE 431 WATERS CORPORATION: BUSINESS OVERVIEW
FIGURE 38 WATERS CORPORATION: COMPANY SNAPSHOT
TABLE 432 WATERS CORPORATION: PRODUCTS & SERVICE OFFERINGS
  11.1.6 BIO-RAD LABORATORIES
TABLE 433 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
TABLE 434 BIO-RAD LABORATORIES: PRODUCT OFFERINGS
  11.1.7 BRUKER CORPORATION
TABLE 435 BRUKER CORPORATION: BUSINESS OVERVIEW
FIGURE 40 BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 436 BRUKER CORPORATION: PRODUCT OFFERINGS
  11.1.8 PERKINELMER
TABLE 437 PERKINELMER: BUSINESS OVERVIEW
FIGURE 41 PERKINELMER: COMPANY SNAPSHOT
TABLE 438 PERKINELMER: PRODUCT OFFERINGS
  11.1.9 SHIMADZU CORPORATION
TABLE 439 SHIMADZU CORPORATION: BUSINESS OVERVIEW
FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT
TABLE 440 SHIMADZU CORPORATION: PRODUCT OFFERINGS
  11.1.10 EUROFINS SCIENTIFIC
TABLE 441 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 442 EUROFINS SCIENTIFIC: SERVICE OFFERINGS
  11.1.11 SARTORIUS
TABLE 443 SARTORIUS: BUSINESS OVERVIEW
FIGURE 44 SARTORIUS: COMPANY SNAPSHOT
TABLE 444 SARTORIUS AG: PRODUCT OFFERINGS
  11.1.12 HORIBA
TABLE 445 HORIBA: BUSINESS OVERVIEW
FIGURE 45 HORIBA: COMPANY SNAPSHOT
TABLE 446 HORIBA: PRODUCT OFFERINGS
  11.1.13 QIAGEN
TABLE 447 QIAGEN: BUSINESS OVERVIEW
FIGURE 46 QIAGEN: COMPANY SNAPSHOT
TABLE 448 QIAGEN: PRODUCT OFFERINGS
  11.1.14 VPROTEOMICS
TABLE 449 VPROTEOMICS: BUSINESS OVERVIEW
TABLE 450 VPROTEOMICS: SERVICE OFFERINGS
  11.1.15 JEOL
TABLE 451 JEOL: BUSINESS OVERVIEW
FIGURE 47 JEOL: COMPANY SNAPSHOT
TABLE 452 JEOL: PRODUCT OFFERINGS
  11.1.16 PROMEGA CORPORATION
TABLE 453 PROMEGA CORPORATION: BUSINESS OVERVIEW
TABLE 454 PROMEGA CORPORATION: PRODUCT OFFERINGS
  11.1.17 CLEAVER SCIENTIFIC
TABLE 455 CLEAVER SCIENTIFIC: BUSINESS OVERVIEW
TABLE 456 CLEAVER SCIENTIFIC: PRODUCT OFFERINGS
  11.1.18 SERVA ELECTROPHORESIS
TABLE 457 SERVA ELECTROPHORESIS: BUSINESS OVERVIEW
TABLE 458 SERVA ELECTROPHORESIS: PRODUCT OFFERINGS
  11.1.19 ANALYTIK JENA
TABLE 459 ANALYTIK JENA GMBH: BUSINESS OVERVIEW
TABLE 460 ANALYTIK JENA: PRODUCT OFFERINGS
  11.1.20 RIGAKU CORPORATION
TABLE 461 RIGAKU CORPORATION: BUSINESS OVERVIEW
TABLE 462 RIGAKU CORPORATION: PRODUCT OFFERINGS
  11.1.21 LECO CORPORATION
TABLE 463 LECO CORPORATION: BUSINESS OVERVIEW
TABLE 464 LECO CORPORATION: PRODUCT OFFERINGS
  11.1.22 MASSTECH
TABLE 465 MASSTECH: BUSINESS OVERVIEW
TABLE 466 MASSTECH: PRODUCT OFFERINGS
  11.1.23 MS BIOWORKS
TABLE 467 MS BIOWORKS: BUSINESS OVERVIEW
TABLE 468 MS BIOWORKS: SERVICE OFFERINGS
  11.1.24 ADVION
TABLE 469 ADVION: BUSINESS OVERVIEW
TABLE 470 ADVION: PRODUCT OFFERINGS
  11.1.25 CREATIVE PROTEOMICS
TABLE 471 CREATIVE PROTEOMICS: BUSINESS OVERVIEW
TABLE 472 CREATIVE PROTEOMICS: SERVICES OFFERINGS
11.2 OTHER COMPANIES
  11.2.1 POOCHON SCIENTIFIC
  11.2.2 TECAN GROUP
  11.2.3 PROTEOME FACTORY AG
  11.2.4 APPLIED BIOMICS
  11.2.5 BIOPROXIMITY
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORT
12.5 AUTHOR DETAILS

About

Protein characterization refers to the characterization of proteins, based on protein size, shape, and sequence concentration as well as physiochemical properties such as isoelectric point, molecular weight, relative hydrophobicity, and spectral analysis.

• This market study covers various protein characterization and identification products (instruments, consumables, and services) for arriving at the protein characterization and identification market size from 2012 to 2019
• These products primarily find applications in clinical diagnosis and drug discovery and development. These products also find applications in agricultural and environmental research.

This research study involved the usage of extensive secondary sources, directories, and databases such as Hoovers, Bloomberg BusinessWeek, Factiva, and OneSource, to identify and collect information useful for this technical, market-oriented, and commercial study of the global protein characterization and identification market. The primary sources are mainly several industry experts from core and related industries and preferred suppliers, manufacturers, distributors, service providers, reimbursement providers, technology developers, alliances, standards and certification organizations from companies, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted from various primary respondents, which include key industry participants, subject matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following illustrative figure shows the market research methodology applied in making this report on the global protein characterization and identification market.

In the secondary research process, various secondary sources were referred to identify and collect information for this study. The secondary sources include annual reports, press releases and investor presentations of companies, white papers, journals, certified publications, articles from recognized authors, gold standard and silver standard websites, disease-specific organizations, directories, and databases.

Secondary research was mainly used to obtain key information about the industry’s supply chain, market’s monetary chain, total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, geographical markets, and key developments from both market- and technology-oriented perspectives.

In the primary research process, various primary sources from both supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the protein characterization and identification market. The primary sources from the demand side include academicians, laboratory technicians and technologists, purchase managers in biotechnology and pharmaceutical companies, and researchers.

After the complete market engineering (which includes calculations for market statistics, market crackdown, market size estimations, market forecasting, and data triangulation) extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at.

Primary research was also conducted to identify the segmentation types; industry trends; Porter’s analysis; key players; competitive landscape of protein characterization and identification products supplied by different types of market players; and key market dynamics such as drivers, restraints, opportunities, industry trends, and key player strategies.

In the complete market engineering process both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list key information/insights throughout the report.

Our forecast of the size of the global protein characterization and identification market for 2019 is the product of a bottom-up model constructed by integrating inputs on the key drivers and trends of demand outlined in the main report. In chapters 4 and 5, we have outlined the key drivers and trends that will shape the global protein characterization and identification market. The key drivers that are expected to have a high impact on this market are increasing public and private sector funding for R&D and increasing trend of patent application in biotechnology. Increasing government funding is expected to have a direct impact on the demand of protein characterization and identification products; whereas, technology conversion and commercialization in life science research through increasing trend of patent applications in biotechnology is expected to have an indirect impact on the demand of protein characterization and identification products.

This section provides an overview of the modeling approach adopted and the data sources that were used as inputs for each of the two demand drivers. This section also describes how the data was integrated to develop an overall view of the global protein characterization and identification market by 2019.

The following sections outline the two points mentioned below:

• Growth in R&D expenditure: Data sources were used to understand the increase in research and development across the globe and how this will impact the global spending and demand for protein characterization and identification products
• Increasing number of biotechnology patents: Data sources were used to understand the increasing patents in biotechnology globally and how it would impact the global demand for the protein characterization and identification market